How Smoking Causes COPD: Examination of Immune System Changes

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2005-05-31

Study Completion Date

2012-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A breathing condition known as "chronic obstructive pulmonary disease" (COPD) caused by cigarette smoking is a major health problem. The way by which smoking leads to lung disease is uncertain. Recent research done in animals provides a description of specific changes (that is a reduction) in these immune cell types as a result of cigarette smoke exposure. The study you have been asked to participate in is a pilot study to see if similar changes occur in humans who smoke. The purpose of this study is to evaluate this new method of testing blood in 3 groups of 10 people: normal non-smoking subjects, subjects who smoke with no history of lung disease and subjects who smoke and have smoking related COPD.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Pulmonary Function Changes in 10 Pack Year Smokers With Chronic Bronchitis

NCT00454675

Chronic Bronchitis COPD

COMPLETED

Identifying Early Chronic Obstructive Pulmonary Disease (COPD) Using Health Administrative Data

NCT04966637

Chronic Obstructive Pulmonary Disease (COPD

COMPLETED

Systemic Inflammation in Chronic Obstructive Pulmonary Disease (COPD)

NCT00850863

Chronic Obstructive Pulmonary Disease

UNKNOWN

Macrophages in Smokers' Lung

NCT00298402

Chronic Obstructive Pulmonary Disease Emphysema Chronic Bronchitis

WITHDRAWN

Responses Induced by Smoking in Individuals Being Susceptible and Non-Susceptible for Development of COPD

NCT00807469

Chronic Obstructive Pulmonary Disease

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The mechanism by which smoking leads to damage to lung tissue in susceptible hosts, is uncertain. Recently there has been description of specific changes (that is reduction) in the number and activity of certain key immune cell types - dendritic cells- as a result of cigarette smoke exposure. This work was done in animal models and we would like to develop methods that will allow us to examine if similar changes occur in humans who smoke. Reduced number and activity of dendritic cells would be expected to lead to increased incidence of infection - a common problem in patients with COPD.

Since dendritic cells come to the lung from the bloodstream, and one can detect them in the circulation, we will look at the dendritic cells that are present in the peripheral blood.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Obstructive Pulmonary Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \> 40 years
* Healthy Subjects - Non smokers
* FEV1/FVC \> 70% predicted
* Current Smokers - \> 10 pack year smoking history
* FEV1/FVC \> 70% predicted
* Current Smokers with COPD - \> 10 pack year smoking history
* FEV1/FVC \< 70% predicted
* Able to give informed consent